Efficacy of busulfan-melphalan high dose chemotherapy consolidation (BuMel) in localized high-risk Ewing sarcoma (ES): Results of EURO-EWING 99-R2 randomized trial (EE99R2Loc).
Year: 2016
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Jeremy Whelan, Marie-Cecile Le Deley, Uta Dirksen, Ian Robert Judson, Douglas S. Hawkins, Hendrik Van Den Berg, Ruth Ladenstein, Jarmila Kruseova, Andreas Ranft, Susanne Amler, Nathalie Gaspar, Valerie Laurence, Gwenael Le Teuff, Perrine Marec-Berard, Bernadette Brennan, Keith Wheatley, Bruce Morland, Sandrine Marreaud, Heribert Juergens, Odile Oberlin
Institutions: University College Hospital, University College London, Institut Gustave Roussy, University of Münster, Royal Marsden Hospital, Seattle Children's Hospital, St Anna Children's Hospital, University Hospital Münster, Institut Curie, Institut d’Hématologie et d’Oncologie Pédiatrique, Royal Manchester Children's Hospital, University of Birmingham, Birmingham Children's Hospital, European Organisation for Research and Treatment of Cancer
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2533530907